• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio

    Frontage Bolsters Clinical Services Capabilities

    Sanofi Unveils EUROAPI as Name of New European API Company

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza

    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

    LSNE Expands Fill Finish and Lyophilization Ops
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Virtual Clinical Trials: The Future of Dermatology Studies

    Frontage Bolsters Clinical Services Capabilities

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics

    The Wasdell Group Earns ISO 13485 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    Reed-Lane

    Aphena Pharma Solutions

    Flow Sciences

    Cytovance Biologics
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Reed-Lane

    PCI Pharma Services

    Alcami

    Emergent BioSolutions

    Flow Sciences
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    The Future of Pharmaceutical Manufacturing

    Neo PLM’s Cathal Strain discusses the need for a digital revolution to drive manufacturing innovation

    The Future of Pharmaceutical Manufacturing
    Kristin Brooks, Contract Pharma02.12.20
    In an industry that tends to lag behind others on matters of technology transformation, today’s market pressures are creating an increasingly imperative need for change in pharmaceutical manufacturing practices. The pharmaceutical industry is heavily regulated, and therefore, inherently more complex. An overhaul of operations into the digital era can be disruptive to the supply of life-saving medicines.  

    However, in order to address the challenges that innovative therapeutics, pricing pressures, and global supply chains present, the adoption of digital solutions has become essential. This means moving beyond all paper-based document management systems, leveraging Big Data, artificial intelligence, industrial internet of things (IIoT), and machine-learning for a meaningful impact on pharmaceutical manufacturing to improve processes and quality.

    Cathal Strain, President of Neo PLM, a provider of Product Lifecycle Management solutions for pharmaceutical companies and process manufacturers, discusses the need for change in manufacturing practices and the next generation of technology that can help drive innovation.  –KB

    Contract Pharma: What are the latest breakthrough technologies being implemented by pharmaceutical manufacturers?

    Cathal Strain: Despite an abundance of innovation in new drug therapies, this century has not seen a corresponding adoption of truly breakthrough pharmaceutical manufacturing technologies. In the small molecule sector—the industry’s largest—continuous manufacturing is now a focus area, especially in new drug development. However, that focus has yet to yield any significant advances. The evolution pattern recalls that of process analytical technology (PAT), whose implementation has substantially lagged expectations after starting with great fanfare in the early 2000s. In the large molecule sector, the rise of single-use technologies is seen as a significant trend, at least for lower-volume manufacturing.

    However, none of these initiatives would qualify as a “breakthrough.” At best, the last two decades have been a period of slow evolution for pharma manufacturing in terms of new technology adoption. It is time for Big Pharma to fundamentally change the way it thinks about manufacturing.

    There was a time when pharma companies eagerly embraced emerging technologies, such as automation, to evolve their manufacturing operations. That was before the great shift to outsourced production began some 25 years ago. Since then, the industry's appetite for manufacturing innovation has diminished. The manufacturing supply chain remains mired in paper-based processes and production records—starting with initial tech transfer from R&D and continuing throughout the product lifecycle.

    CP: How is digitization impacting manufacturing operations?

    CS: Digitization, or digital transformation, is the buzzword of this era. However, discussing digitization in pharma manufacturing is difficult considering the paper-based paradigm that continues to dominate shop floors and critical business processes. Many software vendors are casting their products as pathways to digitization, but the same technologies have essentially been available for the past 30 years. These technologies provide a necessary foundation, but the reality is that digitization has not begun to impact pharmaceutical manufacturing operations in a meaningful way.

    CP: What are some of the critical factors for success? What hurdles must be overcome?

    CS: For myriad reasons, pharma manufacturers must move aggressively to participate in the digital revolution that began in other industries—and the consumer world—over 20 years ago. The biggest barrier to progress is the fact that pharma executives have seen no urgent need to evolve their manufacturing operations. Ongoing innovation is critical in other industries, driving the cost reductions and product quality improvements that companies need to survive and compete. However, pharma manufacturing has not been exposed to those same pressures. The industry can still afford inefficiency and regulatory authorities continue to accept antiquated paper-based processes.

    Another hurdle—rarely discussed in the open—is the notion that increasing transparency into pharma manufacturing may reveal problems that could, in turn, present regulatory risks. This attitude must change. Scientists and engineers are driven to uncover and solve manufacturing problems to improve product quality and plant productivity. They can only achieve these objectives with access to comprehensive digital data and advanced analytical tools.

    Pharma must make up a great deal of ground quickly to truly enter the digital age:

    •    Paper- and document-based business processes, from initial product development through shop floor manufacturing, must become obsolete.

    •    Product definition and process knowledge management must be completely digitized. Again, this must occur throughout the product lifecycle, starting with initial tech transfer from R&D. And digital transformation is about more than implementing document management systems. It means placing digital process design, modeling and simulation at the center of the manufacturing systems architecture.

    •    Manufacturers must deploy much more robust measurement and control systems on the shop floor. Just as automation has revolutionized other manufacturing industries, recipe-based automation is the only pathway to innovation in drug making. Advanced automation will be an essential component of continuous manufacturing, wherever that technology will be used.

    •    With a strong foundation in place, pharma will be well positioned to achieve full digital transformation. Newer technologies that fall under the “Big Data” umbrella—such as cloud-based services, the industrial internet of things (IIoT), artificial intelligence and machine-based learning—will become accessible and drive a new era of innovation.

    CP: Taking into consideration the unique challenges the pharmaceutical industry faces bringing operations into the digital era, what steps can it take to minimize the disruption of the supply of medicines?

    CS: The dilemma facing pharma manufacturers is digitizing their operations without disrupting the supply chain or raising regulatory concerns. A phased approach to digital transformation can help strike this balance.

    We have established the need to replace document-based approaches to tech transfer, process knowledge management and quality assurance with an integrated digital structure that puts process design, modeling and simulation at the center of the IT architecture. This shift is foundational to digital transformation, but will require significant business process re-engineering. The good news is that it can be achieved without negatively impacting shop floor operations. On the contrary, a digital design-centric approach will enhance shop floor operations substantially by automating the creation of recipes for manufacturing execution and control systems.

    That said, pharma manufacturers have underachieved when it comes to implementing the shop floor technologies required to enable fully recipe-driven manufacturing operations. The necessary level of process automation cannot be attained quickly. One step pharma manufacturers can take toward shop floor digitization—while not ideal—is implementing MES to achieve a paperless, Electronic Batch Record environment. MES vendors must do their part by providing more innovative solutions that allow customers to deploy EBR cost-effectively. Manufacturers should ultimately be striving for end-to-end process automation. To enable this transition, control system vendors must also make their wares more accessible from a cost standpoint.

    Finally, pharma manufacturers must digitize downstream activities such as batch review and release and advanced process analytics. That will open the door to leveraging the technologies driving Industry 4.0 such as IIoT, machine learning and artificial intelligence.

    CP: What do you anticipate for the future of the pharmaceutical manufacturing industry?

    CS: The FDA issued its industry guidance “Pharmaceutical cGMPs for the 21st Century: A Risk-Based Approach” in the early 2000s. That document encouraged the increased use of information and digital technologies—particularly PAT. In the intervening years, initiatives such as quality by design (QbD) and right-first-time manufacturing have received a great deal of attention. Yet for all this discussion, little has changed.

    Moving forward, however, the status quo is unsustainable. The workforce is increasingly comprised of those that are digital savvy. Pharma manufacturers cannot expect a laboriously document-intensive industry to inspire the finest engineering minds. To attract top talent, pharma manufacturers must empower their workforces with the best possible tools for the job. That means equipping shop floors with technologies that provide the comprehensive digital data necessary to truly ensure the highest product quality and manufacturing efficiency.

    Peter Drucker said, “You can only improve what you can measure.” Taking a step back, it is also true that you can only prove what you can measure—and that includes pharmaceutical product quality. Today’s paper records don’t prove much, no matter how many signatures they bear.

    It is time for pharma manufacturers to set their sights on the digital age. I anticipate they will.


    Cathal Strain is CEO of Neo PLM, the company that pioneered digital design-based Process PLM. Cathal founded Neo in 2011 with the vision of bringing third-millennium PLM capabilities to pharmaceutical companies and other process manufacturers. Today, leading pharmaceutical manufacturers are deploying Neo’s technology at sites around the world. Cathal previously spent over 30 years at Pfizer, where he led the design, development and implementation of the world’s first integrated PLM solution for process manufacturing.
    Related Searches
    • pharma companies
    • Tech Transfer
    • it
    • mes

    Related Online Exclusives

    • Clinical Trials | Drug Development | Information Technology
      Advancing Digital Endpoints in Clinical Trials

      Advancing Digital Endpoints in Clinical Trials

      An end-to-end approach to managing wearable devices through clinical development.
      Kristin Brooks, Contract Pharma 12.14.20

    • Drug Development | Information Technology
      Trade Secret Litigation: Vulnerabilities Within Pharma Amid Hacking Efforts

      Trade Secret Litigation: Vulnerabilities Within Pharma Amid Hacking Efforts

      Theft of IP belonging to companies developing biologics and other drugs, including COVID-19 treatments and vaccines, poses a threat to innovation.
      Kristin Brooks, Contract Pharma 08.19.20

    • Drug Development | Information Technology
      Advancing AI Initiatives in R&D

      Advancing AI Initiatives in R&D

      Richard Lee of ACD/Labs discusses the possibilities of using AI in R&D, and what this outlook means for IT leaders at pharmaceutical organizations.
      Kristin Brooks, Contract Pharma 06.11.20


    • Clinical Trials | CRO News | Drug Development | Information Technology | R&D
      CRO Industry Update

      CRO Industry Update

      Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.
      Kristin Brooks, Contract Pharma 04.27.20

    • Clinical Trials | Information Technology | QA/QC
      Managing Clinical Trials Amid the Coronavirus Pandemic

      Managing Clinical Trials Amid the Coronavirus Pandemic

      Patrick Hughes of CluePoints discusses the impact on clinical trials and how leveraging data may herald a long overdue paradigm shift in the industry.
      Kristin Brooks, Contract Pharma 04.06.20

    • Clinical Trials | CRO News | Drug Development | Industry News | Information Technology
      Janssen, PRA Design First Mobile Virtual Trial

      Janssen, PRA Design First Mobile Virtual Trial

      Kent Thoelke and Greg Licholai of PRA discuss the alliance, advances that have made virtual clinical trials possible, and the obstacles that remain
      Kristin Brooks, Contract Pharma 01.06.20


    • Clinical Trial Materials | Clinical Trials | Information Technology
      Contract Pharma’s 20th Anniversary Series: Clinical Supply

      Contract Pharma’s 20th Anniversary Series: Clinical Supply

      Technology plays a big role in clinical trials, supplies, and the rise of patient-centricity
      Kristin Brooks, Contract Pharma 10.29.19

    • Clinical Trials | CRO News | Drug Development | Information Technology | R&D
      Contract Pharma’s 20th Anniversary Series: CRO Perspective

      Contract Pharma’s 20th Anniversary Series: CRO Perspective

      Randy Marchbanks of PPD discusses how CRO operations have evolved to accommodate changing industry needs
      Kristin Brooks, Contract Pharma 10.28.19

    • Clinical Trials | Information Technology
      Clinical Trial Technology

      Clinical Trial Technology

      The use of new technology to monitor and manage clinical trials.
      Ricky Lakhani, Director of Product Management, PHARMASEAL 10.25.19


    • Clinical Trials | Drug Development | Information Technology
      Better Collaboration is Key to Speeding Trials

      Better Collaboration is Key to Speeding Trials

      Clinical leaders discuss bringing together disparate processes and systems for improved collaboration and more efficient trial execution at Veeva R&D Summit
      Jim Reilly, vice president of clinical strategy at Veeva Systems 10.18.19

    • Information Technology | Serialization | Supply Chain
      Serialization: A Lens Into the Digital Value Network

      Serialization: A Lens Into the Digital Value Network

      Tracelink’s Roddy Martin talks about what the future holds for a serialized pharma supply chain
      Tim Wright, Editor, Contract Pharma 06.11.19

    • Drug Discovery | Information Technology
      Leveraging Deep Learning in Drug Research

      Leveraging Deep Learning in Drug Research

      Dr. Christopher Bouton of Vyasa Analytics discusses the company’s deep learning Cortex and how it’s addressing R&D challenges
      Kristin Brooks, Contract Pharma 04.01.19


    • Clinical Trials | Information Technology
      The New Horizon: Metaprise Analytics in Life Sciences

      The New Horizon: Metaprise Analytics in Life Sciences

      Going beyond enterprise analytics to metaprise analytics—patient-centric systems that create a data driven trial team
      Michelle Longmire, MD, CEO & Founder Medable 03.22.19

    • Fill/Finish | Information Technology
      Manufacturing Equipment Insights

      Manufacturing Equipment Insights

      Dr. Andreas Mattern of Bosch Packaging Technology talks pharma trends, flexible equipment, and Industry 4.0
      Kristin Brooks, Contract Pharma 03.08.19

    • Drug Development | Drug Discovery | Information Technology
      Implementing AI in Drug Discovery

      Implementing AI in Drug Discovery

      Niklas Sandler and Jukka Corander of Nanoform discuss AI and increasing the likelihood of identifying successful compounds
      Kristin Brooks, Contract Pharma 02.22.19

    Trending
    • Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Baxter, Novavax Ink Sterile Manufacturing Agreement
    • Precision Medicine Group Acquires Project Farma
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    Breaking News
    • KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    • Frontage Bolsters Clinical Services Capabilities
    • Sanofi Unveils EUROAPI as Name of New European API Company
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Precision Medicine Group Acquires Project Farma
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Brown Fat Associated with Reductions in Chronic Disease Risk
    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    Amyris Named a Top Social & Environmental Impact Company
    L'Oréal Bans Animal Hair in Brushes
    Ashland Launches Antaron ECo Gel
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login